Gene therapy is a revolutionary field in modern medicine, offering transformative potential to treat and potentially cure a wide range of genetic and acquired diseases. By addressing the root cause of ...
Cell and gene therapies represent a transformative frontier in modern medicine, offering potential cures for previously untreatable conditions. However, securing intellectual property (IP) protection ...
Oncologists' experience with CGT has increased, with more patients treated and earlier lines of therapy being utilized.
Data demonstrates sustained clinical improvements in pain, stiffness and function for up to 156 weeks following a single administration of ...
FDA accepts Rocket Pharmaceuticals' resubmission for Kresladi gene therapy in severe LAD-I, with a decision expected by March ...
An increasing demand for gene therapies is focusing the industry on enhancing production capabilities, transitioning from ...
Decades ago, researchers showed that Down syndrome (also known as trisomy 21), was caused when individuals carried an extra copy of chromosome 21. Down syndrome is also the most common genetic cause ...
Researchers announce breakthrough results for AMT-130, the first disease-modifying treatment for Huntington's disease, with ...
Pharmaceutical Technology on MSN
Affinia raises $40m for gene therapy development
Gene therapy company Affinia Therapeutics has raised $40m in a Series C funding round, led by New Enterprise Associates (NEA).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback